Home > Drug Search >
  • Targets: Synaptic vesicle glycoprotein 2A (SV2A)
  •   > 
Drug Filter
Status:
Approved (2) Phase Ⅱ (3) Phase Ⅰ (2)
Clinical Stage:
Active (3) Discontinued (2)
Company:
UCB (3) Karolinska Institutet (KI) (1) Soricimed (1) Vivolux (2) AstraZeneca (1)
Indication:
Adjunct treatment for epilepsy (1) Epilepsy/Seizures (3) Multiple myeloma (MM) (1) Ovarian cancer (1) Partial seizures (2) Solid tumours (2) Thrombosis (1)
Country:
Aprv. Year:
1999 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top